Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04794322Recruiting

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Role: collaborator

NCT04219098Not ApplicableCompleted

Pain After Preoperative UltraSound Guided Hip Injections for Total Hip Arthroplasty (PUSH)

Role: lead

NCT01490502Phase 3Completed

Vitamin D Supplementation in Multiple Sclerosis

Role: collaborator

NCT02638480Not ApplicableUnknown

Effectiveness of KneeMD on Flexion Contracture in Total Knee Arthroplasty Patients

Role: lead

NCT02341430Phase 4Completed

A Longitudinal Prospective Outcomes Study of Laparoscopic Abdominal Wall Hernia Repair Using Symbotex™ Composite Mesh

Role: lead

NCT02108561Unknown

Breast Cancer Tumor Heterogeneity

Role: lead

NCT02360735Not ApplicableTerminated

Manual Lymph Drainage

Role: lead

NCT01857505Withdrawn

Hip Replacement in a High Volume Community Hospital: Effect on Length of Stay and Hospital Cost

Role: lead

All 8 trials loaded